|
|
|
|
Ashcraft & Gerel
LLP
|
|
|
|
Zelnorm (Tegaserod) Associated With Increased Risk of Heart Attacks and Strokes
[Introduction: If you or a loved one had injuries consisting of a heart attack or stroke which you believe may have resulted from use of the drug Zelnorm (Tegaserod), you may have a lawsuit that should be pursued. Although our lawyers who handle Zelnorm (Tegaserod) lawsuits are located in Maryland (MD), Virginia (VA) and Washington, D.C. (DC), our drug litigation and medical product liability lawsuits are national in scope, and our lawyers who handle these suits are prepared to file lawsuits and litigate Zelnorm (Tegaserod) cases, claims and lawsuits across the country. Therefore, regardless of what state you're from, please fill out our inquiry form on this web site or email us so that Ashcraft & Gerel, LLP can have a lawyer familiar with the litigation over Zelnorm (Tegaserod) contact you to discuss your claim and the potential for a lawsuit.]
On March 28, 2007, the Food and Drug Administration (FDA) asked Novartis Pharmaceuticals to voluntarily stop selling
Zelnorm (Tegaserod), a medicine used for the treatment of women with constipation related irritable bowel syndrome, (sometimes called IBS) and patients younger than 65 years of age with chronic constipation. The FDA has concluded that the benefits of
Zelnorm (Tegaserod) no longer outweigh the risk, based on a recent finding of increased risk of serious cardiovascular events such as heart attack
(myocardial infarction) and stroke associated with use of the drug. Novartis,
in what amounts, in effect, to a recall, has agreed to stop marketing the drug
immediately.
Zelnorm (Tegaserod) is a prescription medication approved for short term treatment of women with irritable bowel syndrome with constipation and for patients under 65 years of age with chronic constipation. Throughout February and March 2007, Novartis reported to
the FDA the results of a new safety analysis of 29 clinical studies of Zellnorm. The data from all the studies were combined to assess the chance of adverse effects on the heart and blood vessels. Over 11,600 patients treated with
Zelnorm (Tegaserod) were compared to over 7,000 patients treated with placebo. The analysis showed that patients treated with Zelnorm had a higher chance of having heart
attacks (myocardial infarctions), strokes and angina pectoris (severe chest pain) than did those who were treated with placebo. Thirteen Zelnorm
treated patients (or .1%) had confirmed heart attacks, strokes or angina, and only one placebo-treated patient (or 0.01%) had symptoms of a stroke that went away without complication. The average age of patients in these studies was 43 years and most patients – 88% -- were women.
The FDA (Food and Drug Administration) has issued a public health advisory recommending the following:
Zelnorm (Tegaserod) has also been linked to serious cases of ischemic colitis and other types of intestinal ischemia. In some cases, these adverse events have led to hospitalization, surgery and even death.
If you think you or a loved one may have suffered an injury or damages as a result of
Zellnorm (Tegaserod), you owe it to yourself to speak to an experienced
pharmaceutical or drug attorney to see if you have a case and to discuss the possibility of bringing a lawsuit to recover for your damages and injuries. The attorney will be able to ascertain if you have a claim for which a lawsuit can be pursued and whether the case and lawsuit can be brought to a successful settlement, verdict, award or other recovery, and the experienced lawyer will be able to advise you on any deadlines for bringing your legal claim for damages. Please contact the law firm of Ashcraft & Gerel, LLP to discuss your case with an experienced
pharmaceutical or drug lawyer in our Drug Litigation Department.
The lawyers at Ashcraft and Gerel, LLP have been leaders in pursuing lawsuits involving unsafe
drugs and medical devices. Our attorneys have successfully brought about verdicts, settlements,
awards or other recoveries in lawsuits on behalf of clients who have been injured by Fen-Phen,
Rezulin, Propulsid, Phenylpropanolamine (PPA), Baycol, breast implants, AIDS tainted
blood and many other drugs and medical devices.
We have a toll free number to reach an attorney to answer your questions with regard to your
specific case. That number is 1-800-829-7037. Please ask to speak to Robert Samet, and he will
place you in touch with one of our Zelnorm (Tegaserod) lawyers. If you would prefer, please feel free to
e-mail us or complete the
help inquiry form on this web
site. Please be sure to include your name, address, telephone number (if you wish to be called), email address and the exact nature of your question, so that our
lawyer can provide you with the specific information you seek about Zelnorm (Tegaserod)
lawsuits.
[ Return to Homepage ] [ Help ] [ Learn About Ashcraft & Gerel ] [ See Our Offices and Attorneys ] [ Email Us ] [ Links ] [Resources] [AG Friends & Associates] [ Contingent Fees in Personal Injury Litigation ] [ Workers' Compensation ] [Maryland Workers' Compensation] [District of Columbia Workers' Compensation] [Virginia Workers' Compensation] [ Product Liability Law ] [ Cerebral Palsy ] [ Medical Malpractice ] [ Automobile Accident Litigation ] [Maryland, Virginia and D.C. Injuries and Accidents] [ Birth Injury Litigation ] [ Social Security Disability ] [ Fen Phen Litigation ] [ Asbestos Litigation ] [ Toxic Tort Litigation ] [ Breast Implant Litigation ] [ Whistle Blower Litigation ] [ Construction Litigation ] [ Railroad Worker (FELA) Litigation ] [ Propulsid Litigation ] [ PPA Litigation ] [ Nursing Home Malpractice ] [ Sulzer Defective Hip Implants ] [ Defense Base Act Claims ] [ Baycol Claims ] [ Other Hip Implant Claims ] [ Thimerosal Mercury Poisoning Autism Claims ] [ Olympus Bronchoscope Claims ] [ Serzone Liver Damage Claims ] [Ephedra Claims] [Crestor Claims] [ Meridia Claims ] [ Lead Paint Claims ] [ Vioxx Claims ] [Celebrex Claims] [Bextra Claims] [Ortho Evra Claims]
